HomeREGULATORY
REGULATORY

Japan Approves Nesp “Biosame,” Eyes Riveted on December Listing
(Aug.16.2018)

The Ministry of Health, Labor and Welfare (MHLW) on August 15 approved a slew of new generic drugs ahead of the next generic reimbursement listing in December, including a so-called “biosame” version of Kyowa Hakko Kirin’s flagship renal anemia drug Nesp (darbepoetin alfa) ...
(LOG IN FOR FULL STORY)

News Calendar